Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1968 Nov;23(6):590–597. doi: 10.1136/thx.23.6.590

A comparison of the actions of different bronchodilators in asthma

Bernard J Freedman 1, Peter Meisner 2, G B Hill 3
PMCID: PMC471859  PMID: 4388005

Abstract

The actions of the following pressurized bronchodilators were compared by administration to 24 asthmatics: (1) Medihaler Iso Forte, (2) Alupent, (3) Medihaler-duo, (4) Bronchilator, and (5) Prenomiser Plus. These contained one or more of the following: isoprenaline, orciprenaline, isoetharine, phenylephrine, atropine methonitrate, and thenyldiamine. The dose was a single discharge from the container. The response was assessed by calculating the mean percentage change in F.E.V. at intervals after inhalation.

The mean peak rises were respectively (1) 49·4%, (2) 43·6%, (3) 36·2%, (4) 33·5%, and (5) 23·5%. The amplitude of peak response to isoprenaline was related to the logarithm of the dose. Weight for weight, orciprenaline had a peak bronchodilator activity 41·5% that of isoprenaline and isoetharine 50%. The preparations did not differ significantly in the time taken to reach maximum response, which varied from 5 to 60 minutes; three-quarters of the maxima occurred within 15 minutes.

The half-life for Alupent was 2 hours; for Medihaler-duo, which contains 240 μg. of phenylephrine per dose, it was 1¼ hours; for the remaining preparations it was about 1 hour. The decay rate, after the first half-hour, was 6% of the basal F.E.V. per hour for Medihaler-duo; for the other preparations it was 10-12%. In the doses given, Alupent yielded 20% and 30% increases lasting 130 and 67 minutes; after Medihaler Iso Forte these lasted 78 and 46 minutes. Similar comparative experiments, designed to eliminate effects of dosage difference, are desirable. Rebound bronchoconstriction occurred in 23% of 92 experiments. There was no response to propellent alone. The mean percentage change in F.E.V. may not be the best way of expressing results.

Full text

PDF
590

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALTOUNYAN R. E. VARIATION OF DRUG ACTION ON AIRWAY OBSTRUCTION IN MAN. Thorax. 1964 Sep;19:406–415. doi: 10.1136/thx.19.5.406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Astin T. W., Penman R. W. Airway obstruction due to hypoxemia in patients with chronic lung disease. Am Rev Respir Dis. 1967 Apr;95(4):567–575. doi: 10.1164/arrd.1967.95.4.567. [DOI] [PubMed] [Google Scholar]
  3. Attila M., Muittari A. The effect of bronchodilator aerosols on the peak expiratory flow rate in asthmatic patients. Acta Med Scand. 1966 Oct;180(4):421–427. doi: 10.1111/j.0954-6820.1966.tb02854.x. [DOI] [PubMed] [Google Scholar]
  4. CAPEL L. H., FLETCHER E. C. SPIROMETRIC INTEGRALS AFTER ISOPRENALINE AND ATROPINE IN ASTHMA. Br J Dis Chest. 1964 Oct;58:174–180. doi: 10.1016/s0007-0971(64)80004-8. [DOI] [PubMed] [Google Scholar]
  5. CHAMBERLAIN D. A., MUIR D. C., KENNEDY K. P. Atropine methonitrate and isoprenaline in bronchial asthma. Lancet. 1962 Nov 17;2(7264):1019–1021. doi: 10.1016/s0140-6736(62)92704-6. [DOI] [PubMed] [Google Scholar]
  6. COHEN A. A., HALE F. C. COMPARATIVE EFFECTS OF ISOPROTERENOL AEROSOLS ON AIRWAY RESISTANCE IN OBSTRUCTIVE PULMONARY DISEASES. Am J Med Sci. 1965 Mar;249:309–315. doi: 10.1097/00000441-196503000-00010. [DOI] [PubMed] [Google Scholar]
  7. Crompton G. K. A comparison of responses to bronchodilator drugs in chronic bronchitis and chronic asthma. Thorax. 1968 Jan;23(1):46–55. doi: 10.1136/thx.23.1.46. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. DAUTREBANDE L., LOVEJOY F. W., Jr, McCREDIE R. M. New studies on aerosols. XVIII. Effects of atropine microaerosols on the airway resistance in man. Arch Int Pharmacodyn Ther. 1962 Sep 1;139:198–211. [PubMed] [Google Scholar]
  9. EDWARDS G. ORCIPRENALINE IN TREATMENT OF AIRWAYS OBSTRUCTION IN CHRONIC BRONCHITIS. Br Med J. 1964 Apr 18;1(5389):1015–1017. doi: 10.1136/bmj.1.5389.1015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. EL-SHABOURY A. H. CONTROLLED STUDY OF A NEW INHALANT IN ASTHMA AND BRONCHITIS. Br Med J. 1964 Oct 24;2(5416):1037–1040. doi: 10.1136/bmj.2.5416.1037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. ENGELHARDT A., HOEFKE W., WICK H. [On the pharmacology of the sympathomimetic 1-(3,5-dihydroxyphenyl)-1-hydroxy-2-isopropylaminoethane]. Arzneimittelforschung. 1961 Jun;11:521–525. [PubMed] [Google Scholar]
  12. FEINMANN L., NEWELL D. J. ISOPRENALINE IN THE TREATMENT OF CHRONIC BRONCHITIS; A CONTROLLED TRIAL OF DIFFERENT METHODS OF ADMINISTRATION. Br J Dis Chest. 1963 Jul;57:140–146. doi: 10.1016/s0366-0850(63)80059-9. [DOI] [PubMed] [Google Scholar]
  13. Fischer M., Mielke U. Vergleichende Untersuchungen über die Wirkung von Aludrin und Alupent als Sprüh-Aerosole. Med Klin. 1965 Nov 5;60(45):1824–1827. [PubMed] [Google Scholar]
  14. GOLDFARB A. A., ROMANOFF A. Clinical evaluation of a new triple drug aerosol for asthma. Ann Allergy. 1962 May;20:307–314. [PubMed] [Google Scholar]
  15. HERSCHFUS J. A., BRESNICK E., LEVINSON L., SEGAL M. S. A new sympathomimetic amine (neosuprel) in the treatment of bronchial asthma. Ann Allergy. 1951 Nov-Dec;9(6):769–773. [PubMed] [Google Scholar]
  16. Hoffbrand B. I., Hoffbrand M. I., Hill I. D., Heaf P. J. Trial of bronchodilator drugs given by metered aerosol with a comparison of two bedside methods of estimating airway resistance. Br Med J. 1966 Apr 23;1(5494):1014–1016. doi: 10.1136/bmj.1.5494.1014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Illig H. Die Wirkung verschiedener Dosier-Aerosole auf die asthmatische Dyspnoe (Doppelblindversuch) Med Klin. 1965 Sep 3;60(36):1452–1454. [PubMed] [Google Scholar]
  18. KENNEDY M. C., THURSBY-PELHAM D. C. SOME ADRENERGIC DRUGS AND ATROPINE METHONITRATE GIVEN BY INHALATION FOR ASTHMA: A COMPARATIVE STUDY. Br Med J. 1964 Apr 18;1(5389):1018–1021. doi: 10.1136/bmj.1.5389.1018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kennedy M. C. "Bronchodilator" action of deptropine citrate with and without isoprenaline by inhalation. Br Med J. 1965 Oct 16;2(5467):916–917. doi: 10.1136/bmj.2.5467.916. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. LANDS A. M., LUDUENA F. P., GRANT J. I., ANANENKO E. The pharmacologic action of some analogs of 1-(3,4-dihydroxyphenyl)-2-amino-1-butanol (ethylnorepinephrine). J Pharmacol Exp Ther. 1950 May;99(1):45–56. [PubMed] [Google Scholar]
  21. LOCKETT M. F. DANGEROUS EFFECTS OF ISOPRENALINE IN MYOCARDIAL FAILURE. Lancet. 1965 Jul 17;2(7403):104–106. doi: 10.1016/s0140-6736(65)92221-x. [DOI] [PubMed] [Google Scholar]
  22. Mushin G. J. Time factor in the measurement of response to bronchodilators. Thorax. 1967 Nov;22(6):538–542. doi: 10.1136/thx.22.6.538. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. PICKWORTH K. H., WESTWOOD J. USE OF THE WRIGHT PEAK FLOW METER; A DOUBLE-BLIND TRIAL OF TWO BRONCHODILATOR AEROSOLS. Practitioner. 1965 Feb;194:260–264. [PubMed] [Google Scholar]
  25. Prime F. J. The relief of airways obstruction by deptropine citrate and isoprenaline. Br J Dis Chest. 1968 Apr;62(2):81–87. doi: 10.1016/s0007-0971(68)80038-5. [DOI] [PubMed] [Google Scholar]
  26. SCADDING J. G. MEANING OF DIAGNOSTIC TERMS IN BRONCHO-PULMONARY DISEASE. Br Med J. 1963 Dec 7;2(5370):1425–1430. doi: 10.1136/bmj.2.5370.1425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Sinclair J. D. The response of asthmatics to bronchodilator aerosols. N Z Med J. 1966 Aug;65(408):524–527. [PubMed] [Google Scholar]
  28. Speizer F. E., Doll R., Heaf P., Strang L. B. Investigation into use of drugs preceding death from asthma. Br Med J. 1968 Feb 10;1(5588):339–343. doi: 10.1136/bmj.1.5588.339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. WIDDICOMBE J. G., KENT D. C., NADEL J. A. Mechanism of bronchoconstriction during inhalation of dust. J Appl Physiol. 1962 Jul;17:613–616. doi: 10.1152/jappl.1962.17.4.613. [DOI] [PubMed] [Google Scholar]
  30. WOOLCOCK A. J., PAIN M. C. ASSESSMENT OF ORCIPRENALINE ("ALUPENT"), A LONG-ACTING BRONCHODILATOR. Med J Aust. 1964 Jul 18;2:89–90. [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES